Researchers are testing purified resveratrol supplements as a potential preventive measure against bowel cancer, following promising early-stage studies. The trial, launched by the University of Leicester and NIHR, will involve 1,300 patients with polyps. The study aims to determine if resveratrol, along with other treatments, can reduce cancer risks. Previous research indicated that low doses of resveratrol could slow cancer cell growth. The trial represents a significant step in cancer prevention efforts in the UK. Teljes cikk (Euronews.com)